Over the past 10 years, fluorescent semiconductor quantum dot (QD)-biomolecule conjugates have emerged as a powerful new sensing platform showing great potential in a wide range of applications in biosensing, environmental monitoring, and disease diagnosis. This mini-review presents a brief account of the recent development on QD-nucleic acid (NA), particularly NA aptamer, conjugates based biosensors using the Förster resonance energy transfer (FRET) readout mechanism. It starts with a brief introduction to the NA aptamer and QD FRET, followed by example approaches to compact QD-DNA conjugates, target readout strategies and sensing performance, and concluded with challenges and outlook for the QD-NA/aptamer bioconjugate sensors.
NA Aptamer
NA Aptamers are short single-stranded DNA or RNA molecules selected from large, random DNA or RNA molecule pools (e.g. 10 14 -10 15 molecules) by their ability to bind a specific target using an in vitro process termed SELEX (systematic Evlution of Ligand by Explontial Enrichment). [1, 2] It is possible to select a NA aptamer against effectively any target of interest. Once an aptamer sequence is known, it can be produced by chemical synthesis and followed by stringent chemical purification to avoid batch-to-batch variations. Aptamers have several advantageous properties over the widely used antibodies as ligand binding agents, [3, 4] including a wider target choice; higher ligand specificity with comparable binding affinity (nM to pM); production by totally in vitro protocols which combinated with chemical purification,
can eliminate batch-to-batch variation; are more robust against thermal and chemical denaturation (they can sustain several rounds of denaturation/renaturation process without loosing ligand binding affinity), and can easily incorporate bespoke functional groups and/or fluorescent lables site-specifically for easy surface-/bio-conjugation and signal readout. As a result, NA aptamers have been used in developing sensors for a wide range of different targets:
from DNAs, proteins, environmental pollutants, street drugs, viruses to whole cancer cells. [5, 6] 
QD-FRET and Challenges
The unique size-dependent, bright and extremely photo-stable fluorescence of QDs make them well-suited for a range of bio-related applications, imaging, cell tracking/trafficking, and multiplexed sensing etc. [7] [8] [9] Their broad absorption and narrow symmetric emission (with typical FWHMs of~25-40 nm) are particularly attractive to FRET based sensing applications because such spectra characteristics allow for wide selection of excitation wavelengths to minimize direct excitation of the acceptor, reducing background and improving sensitivity.
[ 
Approaches to Compact QD-DNA Conjugates
The most straightforward approach to compact QD-DNA conjugates is to directly bind the DNAs to the QD surface (via Zn 2+ in CdSe/ZnS core/shell QDs). Here two different approaches have been reported: Mattoussi and co-workers [16] used the His 6 -tagged DNA and DHLA-QD selfassembly to produce compact QD-DNA conjugates and efficient FRET (E = 60% for n = 2). They have also used such QD-DNA conjugate for label-free DNA detection by incorporating a DNA molecular beacon. We found that thiolated DNAs could self-assemble onto MPA-or DHLA-QDs, producing compact QD-DNA conjugates and high E at low n situations. [11, 14] Interestingly, the MPA (a monodentate ligand)-QD produced stronger E than the DHLA (a chelative ligand)-QD (80% v.s. 34% for n = 1), suggesting the QD surface capping ligands strongly affect the DNA conformation in the QD-DNA assemblies. For the MPA-QD, the DNA strands may wrap around the QD, yielding small r and strong E; while for the DHLA-QD, the DNA strands are extended, leading to big r and weak E. This was supported by the observation that self-assembled MPA-QDssDNA could not hybridise to its complementary DNA, whereas DHLA-QD-ssDNA could. [11, 14] Similar structural differences were also observed in a recent QD-FP (His 6 -tagged) self-assembly study, where r value for the MPA-QD was found to be~2.5 nm shorter than that of the DHLA-QD despite using identical His 6 -tag-Zn 2+ coordination in the bioconjugation. [23] Another approach to compact QD-DNA conjugate is to covalently couple the DNAs to the QD surface functional groups. The binding strength and chain length of the ligands are critical for structural compactness (sensitivity) and specificity of the resulting QD-DNA conjugate sensor. For example, Algar and Krull [24] prepared compact QD-DNA conjugates with efficient FRET (E up to 52% at n = 1) by coupling amine-modified DNA to a MAA-capped QD. However, its specificity was rather low, with a FRET ratio of only~2 between complementary and non-complementary DNA target, suggesting MAA cannot resist non-specific adsorption. [23] We found that EG 3 capped QD could effectively resist non-specific adsorption while maintaining a relatively compact QD-DNA structure (E = 28% for n = 1), the resulting QD-DNA conjugate is suitable for quantitation of low nM specific complementary DNA. [17] More recently, we have developed a novel CDL that can provide stable, compact and entangled capping to the QD, allowing highly specific detection of pM complementary DNA target. [11, 18] The third common approach to QD-DNA conjugate is via biospecific interactions, e.g.
biotin-streptavidin interaction. [12, 25, 26, [28] [29] [30] This process is very simple, by simply mixing commercially available STV-QD with biotinylated DNA usually lead to reliable, efficient QD-DNA conjugation. The drawback here is the large size of the STV-QD (HR >12 nm), leading to inefficient FRET at low n situations (e.g. E~5% at n = 1). [12] These systems are generally suitable only for high n situations [26, [28] [29] [30] or those using very efficient quenchers, e.g. GNPs. [25] QD-DNA/Aptamer FRET sensors Figure 1 summarises some common readout approaches in QD-NA/aptamer conjugate based biosensors. Schemes (A-E) are QD-DNA conjugate sensors for DNA detection and schemes (F-J) are QD-aptamer sensors for non-DNA target detection. Their specific sensing performance (e.g. detection limit and dynamic range) are summarised in Table 2 . A unique advantage for FRET based biosensor over other techniques is its short range interaction: it only detects species within the FRET range (e.g. < 10 nm), any unbound species are undetected because they cannot participate the FRET process, allowing assays to be carried out in a convenient, separation-free format even with excess of unbound species. [10, 11] Schemes (A-C) are "target on" assays, where hybridisation of target DNA to the QD-DNA conjugate produces the readout FRET signal: (A) directly uses the hybridised DNA targets (dyelabelled) for FRET readout; [11, 18, 24] (B) is a label-free alternative to (A), which uses intercalated dye molecules within the hybridised dsDNA as acceptor for FRET readout; [17] and (C) uses the target DNA to cross-link the QD-capture and dye-labelled reporter DNAs, forming a capture/target /reporter sandwich for FRET readout. [13] (D) uses the FRET change resulting from conformational change of a QD-conjugated molecular beacon upon target DNA hybridisation for signal readout.
[16] (E) is a displacement assay, where target DNA binding displaces the luciferase-DNA from the QD-DNA conjugate, reducing luciferase to QD BRET signal as target readout. [27] Schemes (F-J) show common sensing mechanisms used in QD-aptamer biosensors for non-DNA targets. (F-H) are displacement assays: where target-aptamer binding displaces the signal DNA strands from the QD-aptamer conjugate (e.g. GNP [25] or quencher-linked [26, 28] DNAs in (F); dye-labelled DNAs in (G); [11, 29] and unlabelled DNAs with intercalated dyes in (H)), [30] leading to FRET changes as readout signal. (I) uses the QD fluorescence quenching by QD to bound target electron transfer as signal readout. [31, 32] (J) is target induced assembly assay, [33] where the aptamer sequence is split into two halves, each connected to half of a hermin binding domain. The presence of target assembles the two-half aptamer units, leading to the formation of a complete hermin binding site acting as chemical luminescence centre and CRET signal for target readout. [34, 35] A number of different targets, DNAs, proteins, metal ions and small-molecules, have been detected by the QD-NA/aptamer fluorimetric sensors ( Table 2 ). The sensitivity and dynamic range vary significantly from target to target and assay types. In general, the detection limits achieved for macromolecular targets are significantly lower, by~3 orders of magnitudes, than those for smallmolecule targets (nM v.s. M). This appears to be a positive reflection of the differences in binding affinities (e.g. nM v.s. M) and energies of these two types of aptamer-target binding interactions.
[ [4] [5] [6] Another notable observation is the significantly higher sensitivity achieved for DNA detection by using the SMF readout over conventional FS based assays (48 fM v.s. nM), which can be attributed to the extremely high detection capability of the SMF approach, down to single-molecule (QD) level. [13] For most QD-NA/aptamer biosensors using conventional FS readout, their sensitivities are comparable or better than most other more established electrochemical, [36] surface plasmon resonance [37] or quartz crystal microbalance [38] based biosensors using direct detection without further target amplification (which typically have nM sensitivity for DNA/protein, and M for small-molecule/metal-ion targets). An advantage for the QD-NA/aptamer FRET biosensor is its ratiometric signal, which is effectively insensitive to instrument noise and/or signal fluctuations, allowing for accurate, reliable detection even in the presence of excess of unbound species. [10, 11] It should be noted that most of the QD-FRET biosensors reported so far have only demonstrated the "proof-of-principle" application in clean buffers. Few have showed robust operation in complex media, such as serum or other biological fluids, which are more relevant to real clinical samples, most likely due to limited stability and specificity of current QD-aptamer sensors.
Summary and Outlook
Significant progress in QD-NA/aptamer fluorimetric biosensors has been made over the past 10 years, where several assay formats capable of detection of different targets have been developed.
Thanks for their unique short-range interaction readout mechanism and ratiometric signal, [10, 11] the QD-NA/aptamer FRET based sensors can provide reliable, multiplexed detection of different targets in a convenient, separation-free manner. Since NA aptamers can be selected against virtually any targets of choice, [1] [2] [3] [4] the QD-NA/aptamer sensor thus appears to be a highly promising new sensing platform with broad biotechnological, environmental, and clinical applications. [8] [9] [10] [11] This is evident from the exponential growth in both the numbers of publications and citations over the past 10 years (see Supporting Information, Figure 1 ). Despite these, most QD-NA/aptamer sensors reported so far have only demonstrated "proof-of-principle" applications in clean buffers. Few have attempted in biological fluids or real clinical samples, limited mainly by the sensitivity, specificity and robustness of current QD-NA/aptamer sensors. Specifically, their sensitivity and specificity, especially assay robustness, have yet to match those of current "gold-standard" clinical assays such as ELISA (typically with pM sensitivity). Future researches are likely to focus on improving the sensitivity, specificity and robustness of the QD-aptamer biosensors via optimisation of watersolubilisation [19] and QD-DNA conjugation [20] strategies, and extend their applications in real clinical samples.
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